Navigation Links
GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Date:12/11/2007

PHILADELPHIA, Dec. 11 /PRNewswire-FirstCall/ -- The following is GlaxoSmithKline's (NYSE: GSK) response to the retrospective analysis by the Institute for Clinical Evaluative Sciences (ICES) titled "Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes".

GSK believes that the ICES retrospective analysis of the Ontario Drug Benefit (ODB) database has significant limitations and generates misleading conclusions regarding acute myocardial infarction and death. These conclusions are inconsistent with a more robust body of evidence from large, long-term, prospective, well-designed clinical studies, including ADOPT and RECORD.

-- These long-term trials in diabetic patients comparing rosiglitazone to

other oral anti-diabetic medicines show no increased risk for

cardiovascular events compared to other commonly used medications,

other than the well-known risk of congestive heart failure (CHF) with

thiazolidinedione (TZDs).

-- RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of

Glycaemia in Diabetes) was specifically designed to evaluate the

cardiovascular safety of rosiglitazone, and is therefore the most

robust data available. A recently published interim analysis for

myocardial infarction and death from cardiovascular causes, or from any

cause, showed no statistically significant difference between

rosiglitazone in combination with either metformin or sulfonylurea vs.

the active comparators of metformin plus sulfonylurea.

In addition, the RESULT clinical study specifically examined an elderly diabetic population, ages 59 to 89, in which 43 percent of the patients were gre
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
6. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
7. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
8. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
9. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
10. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 The Pistoia ... the HELM biomolecular representation standard software toolkit and ... HELM (Hierarchical Editing Language for Macromolecules) ... biomolecules (e.g. proteins, nucleotides, antibody drug conjugates) whose ... informatics methodologies impractical or unusable. HELM solves this ...
(Date:6/18/2013)... , June 18, 2013 ... international investment research firm, announces the initiation ... a French biopharmaceutical company developing and marketing ... care indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... comprehensive report examining the investment merits of ...
(Date:6/18/2013)... -- The "Bioinformatics Market By Sector (Molecular Medicine, Agriculture, ... Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Global ... Restraints, and Opportunities in North America , ... and Rest of World. Browse , ... Figures 364 Pages and an in-depth ...
(Date:6/18/2013)... , June 18, 2013  Techne Corporation (NASDAQ: ... it has agreed to acquire 100% ownership of ... Inc. (Bionostics).  Bionostics is a global leader in ... that verify the proper operation of in ... point of care blood glucose and blood gas ...
Breaking Biology Technology:The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5
... Advance Ganaxolone Program for the Treatment of EpilepsyBRANFORD, Conn., ... drugs to treat serious neurological and psychiatric disorders, today ... financing. The funding comes on the heels of the ... ganaxolone as an adjunctive therapy in adults with partial ...
... Ohio State University researchers have developed a new strategy ... grand challenge in physics. , What they,ve discovered could ... of new high-tech materials. , In 2008, the Defense ... to tackle an ambitious problem: trap atoms inside a ...
... Copan Diagnostics, Inc. is proud to announce the first ... Vancouver General Hospital. Copan WASP(R): Walk-Away Specimen Processor is ... samples. The breakthrough technology behind the WASP, coupled with ... automation, make the WASP the first instrument of its ...
Cached Biology Technology:Marinus Pharmaceuticals Raises $20 Million in Series B Financing 2Marinus Pharmaceuticals Raises $20 Million in Series B Financing 3Marinus Pharmaceuticals Raises $20 Million in Series B Financing 4Marinus Pharmaceuticals Raises $20 Million in Series B Financing 5Physicists discover important step for making light crystals 2Physicists discover important step for making light crystals 3Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor 2
(Date:6/19/2013)... , June 19, 2013   ... clinical laboratory diagnostics technology for conducting on-demand, ... diabetes testing, as well as analysis of ... and platelet counts. The new system enables ... lab results for physicians and their patients, ...
(Date:6/19/2013)... patients who received injections of steroids contaminated with ... Compounding Center has found that some patients had ... a worsening of their symptoms and that magnetic ... among those individuals who received injections from highly ... an editorial by UC Davis Assistant Professor of ...
(Date:6/19/2013)... for the journal Genetics this month, neurobiologist ... Amherst describe a new experimental technique they developed that ... proteins in individual cell types in a living organism. ... protein function, Chase says, "because we can only get ... when we isolate its function in a living organism. ...
Breaking Biology News(10 mins):Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 3Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 4Evolution of an outbreak: Complications from contaminated steroid injections 2UMass Amherst researchers develop powerful new technique to study protein function 2UMass Amherst researchers develop powerful new technique to study protein function 3
... GAINESVILLE A multicenter team of childhood cancer researchers ... risk for acute lymphoblastic leukemia, or ALL, the most ... these genetic glitches point to a specific subtype of ... leukemia could improve treatment, says University of Florida researcher ...
... created by lightning strikes, Victor Ugaz, associate professor in ... A&M University, has created a network of microchannels that ... as a three-dimensional vasculature for the support of larger ... was undertaken with colleague Arul Jayaraman and appears in ...
... Mich.---In an effort to keep lakes and streams clean, ... use of phosphorus-containing lawn fertilizers, which can kill fish ... the phosphorus washes out of the soil and into ... reduce phosphorus pollution? That,s been an open question until ...
Cached Biology News:Scientists link genetic glitches to common childhood cancer 2Researcher says microchannels could advance tissue engineering methods 2Researcher says microchannels could advance tissue engineering methods 3Researcher says microchannels could advance tissue engineering methods 4Water quality improves after lawn fertilizer ban, study shows 2
... is a manual heat sealer ideal for low ... instrument can seal a wide range of plates ... The heating element of the sealer is pre-set ... peelable seals when used in conjunction with ABgenes ...
...
...
... be used to test the crossreactivity of ... that are commonly used as blocking reagents ... for 21 different protein preparations on a ... and species specificity, QC of purified antibodies, ...
Biology Products: